Eli Lilly obesity pill beats Novo Nordisk drug in diabetes trial
An indication with the corporate logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024.Scott ...
Tag: trial
Eli Lilly weight reduction pill orforglipron clears trial, paving way for approval
Eli Lilly Biotechnology Center is shown in San Diego, California, U.S. March 1, 2023. Mike Blake | ReutersEli Lilly on ...
Moderna’s flu vaccine shows positive trial results, paving way for combo shot
The Moderna Inc. headquarters in Cambridge, Massachusetts, on March 26, 2024.Adam Glanzman | Bloomberg | Getty ImagesModerna on Monday said ...
Elon Musk says Tesla on course to launch robotaxi trial by end of June
Tesla is about to start a test of its long-promised robotaxi service on schedule in Austin, Texas, by the top of June, Chief Executive Elon ...
Google faces Sept. trial for digital ad monopoly as DOJ pushes for breakup
Google faces a September trial after the Justice Department asked a federal judge on Friday to force the Big Tech ...
Latest blood pressure drug helps individuals with uncontrolled hypertension in trial
A brand new style of medication may help lower blood pressure in individuals with uncontrolled hypertension, researchers reported Saturday on the ...
Eli Lilly Zepbound causes more weight reduction than Novo Nordisk Wegovy: Trial
A mixture image shows an injection pen of Zepbound, Eli Lilly's weight reduction drug, and boxes of Wegovy, made by ...
Eli Lilly’s obesity drug beats rival in head-to-head trial — where Cramer sees shares going next
Latest trial data has cemented Club holding Eli Lilly 's pole position within the highly competitive obesity drug race. The ...
Eli Lilly’s cholesterol pill impresses in trial
A version of this text first appeared in CNBC's Healthy Returns newsletter, which brings the most recent health-care news straight ...
Merck says experimental RSV treatment protected infants in trial
The emblem for Merck is displayed on a screen on the Latest York Stock Exchange on Nov. 17, 2021.Andrew Kelly ...
